Docoh
Loading...

PCSA Processa Pharmaceuticals

Employees

Data from SEC filings
Employee count

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


On June 8, 2021, the Company held its Annual Meeting of Shareholders. The Shareholders voted on five proposals and cast their votes as follows:

1.All five directors were elected to serve until the next Annual Meeting of Shareholders or until their successors have been duly elected and qualified based on the following votes:


Shares
NameForAgainstAbstainBroker Non-Votes
Dr. David Young11,014,3217,905-1,975,184
Dr. Khalid Islam10,950,97071,256-1,975,184
Geraldine Pannu11,011,12311,103-1,975,184
Virgil Thompson10,899,514122,712-1,975,184
Justin Yorke10,854,402167,824-1,975,184


2.Results of the advisory vote relating to compensation of our named executive officers were as follows:


Shares
ForAgainstAbstainBroker Non-Votes
11,011,7507,8312,6451,975,184


3.Results of the advisory vote on the frequency of future advisory votes on executive compensation are below. In accordance with voting results, the Company will conduct an advisory vote on executive compensation every year.


Shares
1 Year2 Years3 YearsAbstainBroker Non-Votes
10,186,391673,62270,03292,1811,975,184


4.The amendment and restatement of the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan to increase the number of shares available for issuance under the Plan by 2,500,000 was approved based on the following votes:


Shares
ForAgainstAbstainBroker Non-Votes
10,509,0529,979503,1951,975,184


5.The appointment of BD & Company Inc. as the independent registered public accounting firm 2021 was ratified based on the following votes.


Shares
ForAgainstAbstainBroker

Non-Votes
12,467,390259,759270,261-